Curran Terrie — SEC Form 4 filings
SEC reporting owner CIK 1690298. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-22 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 117,767 shares, $1,754,369 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 27,052 shares @ $25.03 ($677,095) in Arcutis Biotherapeutics, Inc., filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 6 | — | 4 legs · 47,959 sh · $1,078,274 | 12 |
| Phathom Pharmaceuticals, Inc. (PHAT) | President and Chief Executive, Director | 5 | — | 3 legs · 69,808 sh · $676,096 | 2 |
Form 4 filings — Curran Terrie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 11,148 @ $7.51 · Sale (S): 11,148 @ $25.03 · Option exercise (M): 27,052 @ $8.63 · Sale (S): 27,052 @ $25.03 · Option exercise (M): 11,148 (derivative) @ $0 · Option exercise (M): 27,052 (derivative) @ $0 | EDGAR |
| 2026-08-24 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 1,072 @ $7.51 · Sale (S): 1,072 @ $26.04 · Option exercise (M): 1,072 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 5,778 @ $0 · Grant/award (A): 16,667 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 7,609 @ $0 · Grant/award (A): 20,568 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 342,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 19,109 @ $6.59 | EDGAR |
| 2024-11-13 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 8,687 @ $10.85 | EDGAR |
| 2024-07-17 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 33,848 @ $11.72 | EDGAR |
| 2024-06-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 10,139 @ $0 · Grant/award (A): 27,052 (derivative) @ $0 | EDGAR |
| 2024-03-26 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale (S): 16,851 @ $9.11 | EDGAR |
| 2024-01-22 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 475,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1690298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →